{"schema_version":"secwatch.filing_event.v1","accession":"0001757898-23-000012","form_type":"8-K","ticker":"STE","cik":"0001757898","company_name":"STERIS plc","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.331024+00:00","generated_at":"2026-06-08T16:40:20.085120+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"STERIS reports Q2 FY2024 revenue $1.34B, up 12%; EPS $1.16, adjusted $2.03","bullets":["Revenue of $1.34B increased 12% as reported and 8% constant currency organic from $1.20B in Q2 FY2023.","GAAP diluted EPS $1.16; adjusted diluted EPS $2.03 for the quarter ended Sept 30, 2023.","Fiscal 2024 outlook maintained; no update to prior guidance provided.","Constant currency organic revenue growth of 8% highlights underlying demand strength."],"urls":{"canonical":"https://secwatch.observer/filing/0001757898-23-000012","json":"https://secwatch.observer/filing/0001757898-23-000012.json","markdown":"https://secwatch.observer/filing/0001757898-23-000012.md","text":"https://secwatch.observer/filing/0001757898-23-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757898/000175789823000012/0001757898-23-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757898/000175789823000012/ste-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T16:40:20.085120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ca5a952dc917943aed5a6633d975deebf215b774","claim":"STERIS plc reported fiscal 2024 second quarter ended September 30, 2023 results: revenue $1.34 billion, EPS $1.16 per diluted share. Guidance reaffirmed.","evidence_excerpt":"STERIS Announces Financial Results for Fiscal 2024 Second Quarter • Second quarter revenue growth of 12% as reported and 8% constant currency organic • As reported diluted earnings per share increased to $1.16; adjusted earnings increased to $2.03 • Fiscal 2024 outlook maintained DUBLIN, IRELAND - (November 7, 2023) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 second quarter ended September 30, 2023. Revenue as reported for the quarter increased 12% to $1.34 billion compared with $1.20 billion in the second quarter of fiscal 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1757898/000175789823000012/0001757898-23-000012-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2024 second quarter ended September 30, 2023"},{"label":"Revenue","value":"$1.34 billion"},{"label":"EPS","value":"$1.16 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}